Meeting Highlights 500+ one-on-one partnering meetings between attendees 250+ company executives, investors, patient advocates and large pharma representatives in attendance over the course of the two-day conference 60+ industry experts discussing topics ranging from go-to-market strategies to the latest discoveries in T-cell therapies 50+ presentations by the field’s most prominent publicly traded and emerging private companies 5+ interactive panel sessions addressing critical commercial, scientific, regulatory and market access issues Zero reasons to miss the 2019 meeting!